期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
非典型抗精神病药物治疗痴呆精神行为症状的临床研究 被引量:2
1
作者 沐楠 潘集阳 +6 位作者 唐牟尼 饶冬萍 黄俏庭 陈建平 郁俊昌 邹灿芳 刘文滔 《阿尔茨海默病及相关病杂志》 2018年第3期204-207,共4页
目的:探讨奥氮平、利培酮、喹硫平小剂量短期治疗对痴呆伴发精神行为症状(BPSD)的影响和安全性。方法:连续性入组BPSD患者,随机进入奥氮平、利培酮、喹硫平和空白对照组,随访4周,评定工具:神经精神科问卷(NPI)、治疗副反应量表等。结果:... 目的:探讨奥氮平、利培酮、喹硫平小剂量短期治疗对痴呆伴发精神行为症状(BPSD)的影响和安全性。方法:连续性入组BPSD患者,随机进入奥氮平、利培酮、喹硫平和空白对照组,随访4周,评定工具:神经精神科问卷(NPI)、治疗副反应量表等。结果:2周末喹硫平组的NPI减分值大于空白组,4周末奥氮平和喹硫平组的减分值大于空白组(P<0.05)。和空白组比较,只有喹硫平组便秘不良反应差异有统计学意义(P<0.05)。利培酮组无严重不良事件。结论:奥氮平、喹硫平小剂量、短期使用能有效改善BPSD,利培酮在安全性上可能有优势。 展开更多
关键词 抗精神病药 治疗 痴呆 精神行为症状
下载PDF
Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population 被引量:7
2
作者 HE Xiao-ming ZHANG Zhen-xin +4 位作者 ZHANG Jun-wu ZHOU Yong-tao tang mou-ni WU Cheng-bin HONG Zhen 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第14期1204-1209,共6页
Background Oxidative stress such as low-density lipoprotein (LDL) oxidation is thought to be an important mechanism in Alzheimer's disease (AD). Paraoxonase 1 (PON1), an enzyme located on high-density lipoprote... Background Oxidative stress such as low-density lipoprotein (LDL) oxidation is thought to be an important mechanism in Alzheimer's disease (AD). Paraoxonase 1 (PON1), an enzyme located on high-density lipoprotein, can prevent LDL from oxidation to some extent. It is also a potent cholinesterase inhibitor and an arylesterase, combating organophosphate poisoning and metabolization of environmental neurotoxins which might be responsible for neurodegeneration with aging.We evaluated the association of Gln192Arg polymorphism in the PON1 gene with AD in a Chinese Han ethnic population. Methods Patients and age-matched controls were recruited from outpatient clinics and a population-based epidemiological survey, respectively. Gln192Arg polymorphism in the PON1 gene was detected by allele-specific PCR technique in 521 patients with AD and 578 healthy controls. Results The presence of at least one of PON1 R alleles (Q/R or R/R) was lower in AD patients than in the controls (82.7% vs 87.4%; χ^2 = 4.68, P = 0.03). PON1 gene R allele frequency was lower in AD patients than in the controls (60.7% vs 64.7%; χ^2=3.85, P = 0.05). One-way ANOVA showed that PON1 genotype had no effect on the age of onset for developing AD. Logistic regression analysis demonstrated the age and sex-adjusted odds ratio (OR) for the risk of AD in PON1 of PON1 R allele carriers was 0.71 (P = 0.044, 95%CI, 0.51 - 0.99).Conclusion Our results indicate that Gln192Arg polymorphism in the PON1 gene is associated with AD, and PON1 R allele might be a protective factor for AD in a Chinese Han ethnic population. 展开更多
关键词 Alzheimer disease paraoxonase 1 GENE single nucleotide polymorphism
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部